 | • レポートコード：MRC23Q36553 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の非動物性ソフトジェルカプセル市場について調査・分析し、世界の非動物性ソフトジェルカプセル市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（植物多糖類ソフトカプセル、澱粉ソフトカプセル）、用途別セグメント分析（健康補助食品、医薬品、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Catalent、Procaps Laboratorios、EuroCaps、Best Formulations、Aenova、Captek、Sirio、Bahrain Pharma、Robinson Pharma、Aland、Fuji Capsule、Sunsho Pharmaceutical、Erkangなどが含まれています。世界の非動物性ソフトジェルカプセル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、非動物性ソフトジェルカプセル市場規模を推定する際に考慮しました。本レポートは、非動物性ソフトジェルカプセルの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、非動物性ソフトジェルカプセルに関するビジネス上の意思決定に役立てることを目的としています。 ・非動物性ソフトジェルカプセル市場の概要 - 製品の定義 - 非動物性ソフトジェルカプセルのタイプ別セグメント - 世界の非動物性ソフトジェルカプセル市場規模：タイプ別分析（植物多糖類ソフトカプセル、澱粉ソフトカプセル） - 非動物性ソフトジェルカプセルの用途別セグメント - 世界の非動物性ソフトジェルカプセル市場規模：用途別分析（健康補助食品、医薬品、その他） - 世界の非動物性ソフトジェルカプセル市場規模予測（2018年-2029年） - 非動物性ソフトジェルカプセルの平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - 非動物性ソフトジェルカプセル市場の競争状況およびトレンド ・非動物性ソフトジェルカプセルの地域別市場規模 - 北米の非動物性ソフトジェルカプセル市場規模（2018年-2029年） - アメリカの非動物性ソフトジェルカプセル市場規模（2018年-2029年） - ヨーロッパの非動物性ソフトジェルカプセル市場規模（2018年-2029年） - アジア太平洋の非動物性ソフトジェルカプセル市場規模（2018年-2029年） - 中国の非動物性ソフトジェルカプセル市場規模（2018年-2029年） - 日本の非動物性ソフトジェルカプセル市場規模（2018年-2029年） - 韓国の非動物性ソフトジェルカプセル市場規模（2018年-2029年） - インドの非動物性ソフトジェルカプセル市場規模（2018年-2029年） - オーストラリアの非動物性ソフトジェルカプセル市場規模（2018年-2029年） - 中南米の非動物性ソフトジェルカプセル市場規模（2018年-2029年） - 中東・アフリカの非動物性ソフトジェルカプセル市場規模（2018年-2029年） ・タイプ別セグメント：植物多糖類ソフトカプセル、澱粉ソフトカプセル - 世界の非動物性ソフトジェルカプセルのタイプ別販売量（2018年-2023年） - 世界の非動物性ソフトジェルカプセルのタイプ別売上（2018年-2023年） - 世界の非動物性ソフトジェルカプセルのタイプ別価格 ・用途別セグメント：健康補助食品、医薬品、その他 - 世界の非動物性ソフトジェルカプセルの用途別販売量（2018年-2023年） - 世界の非動物性ソフトジェルカプセルの用途別売上（2018年-2023年） - 世界の非動物性ソフトジェルカプセルの用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Catalent、Procaps Laboratorios、EuroCaps、Best Formulations、Aenova、Captek、Sirio、Bahrain Pharma、Robinson Pharma、Aland、Fuji Capsule、Sunsho Pharmaceutical、Erkang ・産業チェーンと販売チャネルの分析 - 非動物性ソフトジェルカプセル産業チェーン分析 - 非動物性ソフトジェルカプセルの主要原材料 - 非動物性ソフトジェルカプセルの販売チャネル - 非動物性ソフトジェルカプセルのディストリビューター - 非動物性ソフトジェルカプセルの主要顧客 ・非動物性ソフトジェルカプセル市場ダイナミクス - 非動物性ソフトジェルカプセルの業界動向 - 非動物性ソフトジェルカプセル市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global Animal Free Softgel Capsules market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Animal Free Softgel Capsules is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Animal Free Softgel Capsules is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Animal Free Softgel Capsules include Catalent, Procaps Laboratorios, EuroCaps, Best Formulations, Aenova, Captek, Sirio, Bahrain Pharma and Robinson Pharma, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Animal Free Softgel Capsules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Free Softgel Capsules.
The Animal Free Softgel Capsules market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Animal Free Softgel Capsules market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Animal Free Softgel Capsules manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Catalent
Procaps Laboratorios
EuroCaps
Best Formulations
Aenova
Captek
Sirio
Bahrain Pharma
Robinson Pharma
Aland
Fuji Capsule
Sunsho Pharmaceutical
Erkang
Segment by Type
Plant Polysaccharides Softgel Capsules
Starch Softgel Capsules
Segment by Application
Health Supplements
Pharmaceutical
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Animal Free Softgel Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Animal Free Softgel Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Animal Free Softgel Capsules Market Overview
1.1 Product Overview and Scope of Animal Free Softgel Capsules
1.2 Animal Free Softgel Capsules Segment by Type
1.2.1 Global Animal Free Softgel Capsules Market Value Comparison by Type (2023-2029)
1.2.2 Plant Polysaccharides Softgel Capsules
1.2.3 Starch Softgel Capsules
1.3 Animal Free Softgel Capsules Segment by Application
1.3.1 Global Animal Free Softgel Capsules Market Value by Application: (2023-2029)
1.3.2 Health Supplements
1.3.3 Pharmaceutical
1.3.4 Others
1.4 Global Animal Free Softgel Capsules Market Size Estimates and Forecasts
1.4.1 Global Animal Free Softgel Capsules Revenue 2018-2029
1.4.2 Global Animal Free Softgel Capsules Sales 2018-2029
1.4.3 Global Animal Free Softgel Capsules Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Animal Free Softgel Capsules Market Competition by Manufacturers
2.1 Global Animal Free Softgel Capsules Sales Market Share by Manufacturers (2018-2023)
2.2 Global Animal Free Softgel Capsules Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Animal Free Softgel Capsules Average Price by Manufacturers (2018-2023)
2.4 Global Animal Free Softgel Capsules Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Animal Free Softgel Capsules, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Animal Free Softgel Capsules, Product Type & Application
2.7 Animal Free Softgel Capsules Market Competitive Situation and Trends
2.7.1 Animal Free Softgel Capsules Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Animal Free Softgel Capsules Players Market Share by Revenue
2.7.3 Global Animal Free Softgel Capsules Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Animal Free Softgel Capsules Retrospective Market Scenario by Region
3.1 Global Animal Free Softgel Capsules Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Animal Free Softgel Capsules Global Animal Free Softgel Capsules Sales by Region: 2018-2029
3.2.1 Global Animal Free Softgel Capsules Sales by Region: 2018-2023
3.2.2 Global Animal Free Softgel Capsules Sales by Region: 2024-2029
3.3 Global Animal Free Softgel Capsules Global Animal Free Softgel Capsules Revenue by Region: 2018-2029
3.3.1 Global Animal Free Softgel Capsules Revenue by Region: 2018-2023
3.3.2 Global Animal Free Softgel Capsules Revenue by Region: 2024-2029
3.4 North America Animal Free Softgel Capsules Market Facts & Figures by Country
3.4.1 North America Animal Free Softgel Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Animal Free Softgel Capsules Sales by Country (2018-2029)
3.4.3 North America Animal Free Softgel Capsules Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Animal Free Softgel Capsules Market Facts & Figures by Country
3.5.1 Europe Animal Free Softgel Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Animal Free Softgel Capsules Sales by Country (2018-2029)
3.5.3 Europe Animal Free Softgel Capsules Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Animal Free Softgel Capsules Market Facts & Figures by Country
3.6.1 Asia Pacific Animal Free Softgel Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Animal Free Softgel Capsules Sales by Country (2018-2029)
3.6.3 Asia Pacific Animal Free Softgel Capsules Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Animal Free Softgel Capsules Market Facts & Figures by Country
3.7.1 Latin America Animal Free Softgel Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Animal Free Softgel Capsules Sales by Country (2018-2029)
3.7.3 Latin America Animal Free Softgel Capsules Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Animal Free Softgel Capsules Market Facts & Figures by Country
3.8.1 Middle East and Africa Animal Free Softgel Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Animal Free Softgel Capsules Sales by Country (2018-2029)
3.8.3 Middle East and Africa Animal Free Softgel Capsules Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Animal Free Softgel Capsules Sales by Type (2018-2029)
4.1.1 Global Animal Free Softgel Capsules Sales by Type (2018-2023)
4.1.2 Global Animal Free Softgel Capsules Sales by Type (2024-2029)
4.1.3 Global Animal Free Softgel Capsules Sales Market Share by Type (2018-2029)
4.2 Global Animal Free Softgel Capsules Revenue by Type (2018-2029)
4.2.1 Global Animal Free Softgel Capsules Revenue by Type (2018-2023)
4.2.2 Global Animal Free Softgel Capsules Revenue by Type (2024-2029)
4.2.3 Global Animal Free Softgel Capsules Revenue Market Share by Type (2018-2029)
4.3 Global Animal Free Softgel Capsules Price by Type (2018-2029)
5 Segment by Application
5.1 Global Animal Free Softgel Capsules Sales by Application (2018-2029)
5.1.1 Global Animal Free Softgel Capsules Sales by Application (2018-2023)
5.1.2 Global Animal Free Softgel Capsules Sales by Application (2024-2029)
5.1.3 Global Animal Free Softgel Capsules Sales Market Share by Application (2018-2029)
5.2 Global Animal Free Softgel Capsules Revenue by Application (2018-2029)
5.2.1 Global Animal Free Softgel Capsules Revenue by Application (2018-2023)
5.2.2 Global Animal Free Softgel Capsules Revenue by Application (2024-2029)
5.2.3 Global Animal Free Softgel Capsules Revenue Market Share by Application (2018-2029)
5.3 Global Animal Free Softgel Capsules Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Catalent
6.1.1 Catalent Corporation Information
6.1.2 Catalent Description and Business Overview
6.1.3 Catalent Animal Free Softgel Capsules Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Catalent Animal Free Softgel Capsules Product Portfolio
6.1.5 Catalent Recent Developments/Updates
6.2 Procaps Laboratorios
6.2.1 Procaps Laboratorios Corporation Information
6.2.2 Procaps Laboratorios Description and Business Overview
6.2.3 Procaps Laboratorios Animal Free Softgel Capsules Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Procaps Laboratorios Animal Free Softgel Capsules Product Portfolio
6.2.5 Procaps Laboratorios Recent Developments/Updates
6.3 EuroCaps
6.3.1 EuroCaps Corporation Information
6.3.2 EuroCaps Description and Business Overview
6.3.3 EuroCaps Animal Free Softgel Capsules Sales, Revenue and Gross Margin (2018-2023)
6.3.4 EuroCaps Animal Free Softgel Capsules Product Portfolio
6.3.5 EuroCaps Recent Developments/Updates
6.4 Best Formulations
6.4.1 Best Formulations Corporation Information
6.4.2 Best Formulations Description and Business Overview
6.4.3 Best Formulations Animal Free Softgel Capsules Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Best Formulations Animal Free Softgel Capsules Product Portfolio
6.4.5 Best Formulations Recent Developments/Updates
6.5 Aenova
6.5.1 Aenova Corporation Information
6.5.2 Aenova Description and Business Overview
6.5.3 Aenova Animal Free Softgel Capsules Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Aenova Animal Free Softgel Capsules Product Portfolio
6.5.5 Aenova Recent Developments/Updates
6.6 Captek
6.6.1 Captek Corporation Information
6.6.2 Captek Description and Business Overview
6.6.3 Captek Animal Free Softgel Capsules Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Captek Animal Free Softgel Capsules Product Portfolio
6.6.5 Captek Recent Developments/Updates
6.7 Sirio
6.6.1 Sirio Corporation Information
6.6.2 Sirio Description and Business Overview
6.6.3 Sirio Animal Free Softgel Capsules Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sirio Animal Free Softgel Capsules Product Portfolio
6.7.5 Sirio Recent Developments/Updates
6.8 Bahrain Pharma
6.8.1 Bahrain Pharma Corporation Information
6.8.2 Bahrain Pharma Description and Business Overview
6.8.3 Bahrain Pharma Animal Free Softgel Capsules Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Bahrain Pharma Animal Free Softgel Capsules Product Portfolio
6.8.5 Bahrain Pharma Recent Developments/Updates
6.9 Robinson Pharma
6.9.1 Robinson Pharma Corporation Information
6.9.2 Robinson Pharma Description and Business Overview
6.9.3 Robinson Pharma Animal Free Softgel Capsules Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Robinson Pharma Animal Free Softgel Capsules Product Portfolio
6.9.5 Robinson Pharma Recent Developments/Updates
6.10 Aland
6.10.1 Aland Corporation Information
6.10.2 Aland Description and Business Overview
6.10.3 Aland Animal Free Softgel Capsules Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Aland Animal Free Softgel Capsules Product Portfolio
6.10.5 Aland Recent Developments/Updates
6.11 Fuji Capsule
6.11.1 Fuji Capsule Corporation Information
6.11.2 Fuji Capsule Animal Free Softgel Capsules Description and Business Overview
6.11.3 Fuji Capsule Animal Free Softgel Capsules Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Fuji Capsule Animal Free Softgel Capsules Product Portfolio
6.11.5 Fuji Capsule Recent Developments/Updates
6.12 Sunsho Pharmaceutical
6.12.1 Sunsho Pharmaceutical Corporation Information
6.12.2 Sunsho Pharmaceutical Animal Free Softgel Capsules Description and Business Overview
6.12.3 Sunsho Pharmaceutical Animal Free Softgel Capsules Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Sunsho Pharmaceutical Animal Free Softgel Capsules Product Portfolio
6.12.5 Sunsho Pharmaceutical Recent Developments/Updates
6.13 Erkang
6.13.1 Erkang Corporation Information
6.13.2 Erkang Animal Free Softgel Capsules Description and Business Overview
6.13.3 Erkang Animal Free Softgel Capsules Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Erkang Animal Free Softgel Capsules Product Portfolio
6.13.5 Erkang Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Animal Free Softgel Capsules Industry Chain Analysis
7.2 Animal Free Softgel Capsules Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Animal Free Softgel Capsules Production Mode & Process
7.4 Animal Free Softgel Capsules Sales and Marketing
7.4.1 Animal Free Softgel Capsules Sales Channels
7.4.2 Animal Free Softgel Capsules Distributors
7.5 Animal Free Softgel Capsules Customers
8 Animal Free Softgel Capsules Market Dynamics
8.1 Animal Free Softgel Capsules Industry Trends
8.2 Animal Free Softgel Capsules Market Drivers
8.3 Animal Free Softgel Capsules Market Challenges
8.4 Animal Free Softgel Capsules Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer